In conclusion, our data show that loss of Abcg4 did not lead to acceleration of the pathology in a mouse model of Alzheimer’s disease, and that the kinetics of Aß clearance from the brain were not affected by the presence or absence of Abcg4. Here, ABCG4 is linked to Alzheimer disease.